Mackenzie Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,256
| Closed | -$240K | – | 1722 |
|
|
2024
Q3 | $240K | Buy |
+8,256
| New | +$240K | ﹤0.01% | 1287 |
|
|
2024
Q2 | – | Sell |
-10,560
| Closed | -$217K | – | 1561 |
|
|
2024
Q1 | $217K | Buy |
+10,560
| New | +$217K | ﹤0.01% | 1305 |
|
|
2023
Q3 | – | Sell |
-10,465
| Closed | -$311K | – | 1500 |
|
|
2023
Q2 | $311K | Buy |
+10,465
| New | +$311K | ﹤0.01% | 1161 |
|
|
2023
Q1 | – | Sell |
-7,959
| Closed | -$221K | – | 1542 |
|
|
2022
Q4 | $221K | Buy |
7,959
+1,438
| +22% | +$40K | ﹤0.01% | 1209 |
|
|
2022
Q3 | $200K | Sell |
6,521
-377
| -5% | -$11.6K | ﹤0.01% | 1251 |
|
|
2022
Q2 | $203K | Buy |
+6,898
| New | +$203K | ﹤0.01% | 1281 |
|
|
2022
Q1 | – | Sell |
-7,331
| Closed | -$327K | – | 1433 |
|
|
2021
Q4 | $327K | Sell |
7,331
-143
| -2% | -$6.38K | ﹤0.01% | 1108 |
|
|
2021
Q3 | $377K | Buy |
7,474
+3,549
| +90% | +$179K | ﹤0.01% | 1050 |
|
|
2021
Q2 | $308K | Buy |
+3,925
| New | +$308K | ﹤0.01% | 1059 |
|